Jennifer Kan
InvestorGeneral Partner at Juniper · Partner at Climate Capital Syndicate at Climate Capital
San Diego, California, United States
Writes $100K – $1.5M checks
Find your path to Jennifer
135 people in our graph share verified history with Jennifer — schools, employers, funds. One of them is your warm intro.
Alex HartzunlockedJennifer: together at Caltech (2015)
Jennifer: together at 17 Asset Management
Jennifer: together at The University of Tokyo
×6Jennifer: together at Corporatefinanceinstitute
About
Jennifer Kan, a PhD bioengineer whose enzyme engineering was noted in the 2018 Nobel lecture, co-founded a climate biotech spin-out focused on engineered biology and holds patents in biocatalysis.
Invests in
Biotech
Experience
- JuniperGeneral Partner and Co-Foundercurrent2022 — present
- Climate CapitalPartner at Climate Capital Syndicatecurrent2022 — present
- Global Women in VCMembercurrent2022 — present
- 17 Asset ManagementSenior Sustainable Investing Fellow2021 — 2022
- Simpl.CareAdvisor2021 — 2022
- Simpl.CareCo-Founder & President2020 — 2021San Diego, California, United States
- Self-employedScientific and Technical Consultant2019 — 2021
- L'OréalScientific Consultant2019 — 2020
- CaltechPostdoctoral Scholar2015 — 2019
- Cold Spring Harbor LaboratoryHelmsley Fellow in Synthetic Biology2017
- Gonville and Caius College, University of CambridgeResearch Fellow2012 — 2015
- Kyoto UniversityJSPS Research Fellow2012 — 2014Kyoto, Japan
- The University of TokyoResearch Chemist2007 — 2008Tokyo, Japan
- Paul Scherrer Institut PSIGeneral Energy Research Trainee2005Zurich, Switzerland
Skills & more
ManagementLeadership1TeamworkPublic Speaking1Entrepreneurship3Venture Capital1Synthetic Biology3Chemistry8Scientific Writing1Protein ChemistryProject Management1Data Analysis
+12 more
Financial AccountingBusiness AnalyticsBiotechnologyMolecular BiologyStart-upsData ScienceTechnology TransferBiochemistryBusiness StrategyBusiness AnalysisDue DiligenceAccountingFrom Jennifer's professional profile.
Colleagues at Juniper
Frequently asked questions
- Who is Jennifer Kan?
- Jennifer Kan, a PhD bioengineer whose enzyme engineering was noted in the 2018 Nobel lecture, co-founded a climate biotech spin-out focused on engineered biology and holds patents in biocatalysis.
- Where does Jennifer Kan work?
- Jennifer Kan is General Partner at Juniper.
- What does Jennifer Kan invest in?
- Jennifer Kan invests in Biotech.
- What check size does Jennifer Kan write?
- Jennifer Kan typically writes checks of $100K – $1.5M.
- Where did Jennifer Kan go to school?
- Jennifer Kan studied at University of Cambridge (Doctor of Philosophy (PhD), Chemistry); University of Cambridge (MSc, MA); VC University (Venture Finance).
Same school
Also attended University of Cambridge1,412
Stewart ButterfieldCo-founder of Slack and FlickrDemis HassabisCo-founder & CEO of Google DeepMindNiko BonatsosFounder and Managing Partner of VerdictGeorgia StevensonInvestor at Index VenturesHannah SealInvestor at Index VenturesLeah von SiemensPartner at Manta Ray Ventures
+ 1,406 more
Also attended Corporate Finance Institute® (CFI)39
Alain le LouxGENERAL PARTNER at Cottonwood Technology FundTim WeelborgGeneral Partner and co-founder of Homegrown CapitalJai SheridanClient Services Manager at AirTree VenturesOmer KaganowskiAnalyst at Red Dot Capital PartnersDaniel TanFund Director, Principal at Aera VCAugustine IkwuegbuenyiInvestment Associate at Chui Ventures
+ 33 more
Also attended Harvard Business School Online245
MariaInvestor at InvestinorKelsey BeausoleilBusiness Development Network at Redpoint VenturesOliver MarquesPartner, Capital Formation at March Capital PartnersJohn DemeterInvestor at Khosla VenturesJeff RoseAdvisor at AI CapitalRobAdvisor at TFX Capital
+ 239 more
Shared employers
Also worked at 17 Asset Management3
Also worked at L'Oréal149
Gülsah WilkeInvestor at DN CapitalAlexandra DubarInvestor at DaphniKaushik SubramanianVenture capitalist, product personRhie LimPartner, Global Strategy at One Way VenturesJosef NajmPrincipal at Thomson Reuters VenturesAnimesh SharmaVP - GTM at Fireside Ventures Advisory Llp
+ 143 more
Also worked at Cold Spring Harbor Laboratory17
Zach CollinsPartner at Mission BiocapitalUkjin (Jay) KwonPrincipal at SazzeAlley (Welsh) OlshanskyAdvisor at Casdin CapitalSophia MichaelsAssociate at CVS Health VenturesTeri WilleyP2C Managing Director & Officer at Pathway to CuresThomas D. LehrmanManaging Partner at Teamworthy Ventures
+ 11 more
Also worked at Kyoto University14
Shinobu SuzukiScientific Advisor at RDiscoveryYuki HasegawaHead of Healthcare Investment at Whiz Partners Inc.Shota OzawaDirector at MC Healthcare VenturesAnis UzzamanFounder and CEO at Pegasus Tech VenturesOlivier TakJunior Partner at Curie CapitalYoshinori HaraJapan Advisory Board Member at Benhamou Global Ventures
+ 8 more


.jpeg)









.png)




















.webp)













